Investor Conference Call:

Bayer to accelerate transformation

Wednesday, September 30, 2020
Start at approx. 2:00 p.m. EDT (8:00 p.m. CEST)


Bayer to accelerate transformation to address challenging market environment and enable additional growth investments


Adjusted outlook for 2020 confirmed / 2021 sales expected at approximately 2020 levels despite significant headwinds from COVID-19 pandemic; 2021 core earnings per share expected to be slightly below 2020 levels at constant exchange rates / Lower than expected outlook in the agricultural market likely to lead to mid-to-high single-digit billion-euro non-cash impairment charges in the Crop Science business / Strengthening margin profile and funding of additional investments in innovation and growth through additional operational savings, targeted at more than 1.5 billion euros annually as of 2024 / Dividend policy to remain unchanged, payout ratio planned at lower end of 30-to-40 percent range of core earnings per share in the coming years. MORE



Werner Baumann
CEO of Bayer AG



Wolfgang Nickl
CFO of Bayer AG